antibiotic g 418 has been researched along with fluorescein-di-beta-d-galactopyranoside in 1 studies
Studies (antibiotic g 418) | Trials (antibiotic g 418) | Recent Studies (post-2010) (antibiotic g 418) | Studies (fluorescein-di-beta-d-galactopyranoside) | Trials (fluorescein-di-beta-d-galactopyranoside) | Recent Studies (post-2010) (fluorescein-di-beta-d-galactopyranoside) |
---|---|---|---|---|---|
515 | 0 | 102 | 28 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daines, S; Evans, M; Vaulont, S | 1 |
1 other study(ies) available for antibiotic g 418 and fluorescein-di-beta-d-galactopyranoside
Article | Year |
---|---|
Disruption of the adenosine deaminase (ADA) gene using a dicistronic promoterless construct: production of an ADA-deficient homozygote ES cell line.
Topics: Adenosine Deaminase; Animals; Base Sequence; beta-Galactosidase; Blotting, Southern; Cell Line; Exons; Fluoresceins; Galactosides; Gene Targeting; Gentamicins; Homozygote; Kanamycin Kinase; Mice; Models, Genetic; Molecular Sequence Data; Mutagenesis, Insertional; Phosphotransferases (Alcohol Group Acceptor); Protein Biosynthesis; Stem Cells | 1995 |